Detection of twelve nucleotides insertion in the BCR-ABL kinase domain in an imatinib-resistant but dasatinib-sensitive patient with bi-phenotypic acute leukemia

פריטים דומים

• Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutation
  מאת: Sigl, M, et al.
  יצא לאור: (2013)
• Major Molecular Response Achievement in CML Patients Can Be Predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS Ratio at an Earlier Time Point of Follow-Up than Currently Recommended
  מאת: Huet, Sarah, et al.
  יצא לאור: (2014)
• Major molecular response to imatinib in a patient with chronic myeloid leukemia expressing a novel form of e8a2 BCR-ABL transcript
  מאת: Tchirkov, Andrei, et al.
  יצא לאור: (2006)
• BCR-ABL1 mutation development during first-line treatment with dasatinib or imatinib for chronic myeloid leukemia in chronic phase
  מאת: Hughes, T P, et al.
  יצא לאור: (2015)
• BCR-ABL transcript variations in chronic phase chronic myelogenous leukemia patients on imatinib first-line: Possible role of the autologous immune system
  מאת: Clapp, Geoffrey D., et al.
  יצא לאור: (2016)